FDA Inspection 854766 — BioMarin Pharmaceutical, Inc.

BioMarin Pharmaceutical, Inc. — FEI 3004079983

The FDA completed an inspection of BioMarin Pharmaceutical, Inc. on Jun 28, 2013 in Novato, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 28, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Novato, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.